Skip to the page

Data / Form D filings / Allotera Therapeutics, Inc.

Allotera Therapeutics, Inc.: Form D filings

Allotera Therapeutics, Inc., a health care company in St. Louis, MO, filed 4 Form D notices with the SEC between 2021 and 2026. The latest, on July 23, 2026, reports $123.3 million sold of a $163 million offering to 20 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4260 FOREST PARK AVE., SUITE 100, St. Louis, MO, 63110
Phone
(314) 501-1968
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1874298

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 23, 2026Amendment$163,043,971$123,313,778$39,730,19320Aug 22, 2025sec.gov
Sep 8, 2025New notice$163,043,971$109,493,339$53,550,63220Aug 22, 2025sec.gov
Jul 23, 2021New notice$172,000,014$98,500,011$73,500,00327Jul 9, 2021sec.gov
Jul 23, 2021New notice$37,233,405$37,233,4056Apr 13, 2020sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Niall O'DonnellDirector
Bali MuralidharDirector
Peter KienerDirector
Drew DennisonDirector
Kevin LiDirector
Bosun HauDirector
Matthew CooperExecutive Officer
Ayman KabakibiExecutive Officer
Natalie MountDirector
Kumar SrinivasanExecutive Officer, Director
Cherry ThomasExecutive Officer

Other health care companies in Missouri that filed recently

Every Form D from the week of Jul 20, 2026 · All recent filings in Missouri · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Allotera Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.